CL2016000358A1 - Vacuna para adenovirus aviar - Google Patents

Vacuna para adenovirus aviar

Info

Publication number
CL2016000358A1
CL2016000358A1 CL2016000358A CL2016000358A CL2016000358A1 CL 2016000358 A1 CL2016000358 A1 CL 2016000358A1 CL 2016000358 A CL2016000358 A CL 2016000358A CL 2016000358 A CL2016000358 A CL 2016000358A CL 2016000358 A1 CL2016000358 A1 CL 2016000358A1
Authority
CL
Chile
Prior art keywords
avian adenovirus
adenovirus vaccine
vaccine
hepatitis
avian
Prior art date
Application number
CL2016000358A
Other languages
English (en)
Inventor
Michael Hess
Anna Schachner
Ana Marek
Barbara Jaskulska
Original Assignee
Veterinärmedizinische Universität Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48985680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016000358(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Veterinärmedizinische Universität Wien filed Critical Veterinärmedizinische Universität Wien
Publication of CL2016000358A1 publication Critical patent/CL2016000358A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10271—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

VACUNA PARA PREVENIR SINDROME DE HEPATITIS/HIDROPERICARDIO (SHH), HEPATITIS POR CUERPOS DE INCLUSION (IBH) O EROSIÓN DE MOLLEJA (GE) EN AVES, QUE COMPRENDE PROTEINAS DE ADENOVIRUS AVIAR
CL2016000358A 2013-08-19 2016-02-17 Vacuna para adenovirus aviar CL2016000358A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13180860.2A EP2839841A1 (en) 2013-08-19 2013-08-19 Fowl adenovirus vaccine

Publications (1)

Publication Number Publication Date
CL2016000358A1 true CL2016000358A1 (es) 2016-09-09

Family

ID=48985680

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2016000358A CL2016000358A1 (es) 2013-08-19 2016-02-17 Vacuna para adenovirus aviar
CL2018001159A CL2018001159A1 (es) 2013-08-19 2018-04-30 Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2018001159A CL2018001159A1 (es) 2013-08-19 2018-04-30 Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)

Country Status (10)

Country Link
US (1) US10220088B2 (es)
EP (2) EP2839841A1 (es)
JP (1) JP6577470B2 (es)
AU (1) AU2014310676B2 (es)
BR (1) BR112016003338B1 (es)
CA (1) CA2921394C (es)
CL (2) CL2016000358A1 (es)
ES (1) ES2896483T3 (es)
MX (1) MX371174B (es)
WO (1) WO2015024929A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2839841A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839838A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
CN109134646A (zh) * 2017-06-28 2019-01-04 哈药集团生物疫苗有限公司 Ⅰ群血清4型禽腺病毒卵黄抗体的制备方法及其制品
CN110579607A (zh) * 2018-06-08 2019-12-17 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种fadv a病毒间接elisa抗体检测试剂盒及其应用
CN108918869B (zh) * 2018-06-15 2021-12-28 新兴县国研科技有限公司 fiber2蛋白及其重组蛋白在检测血清4型禽腺病毒抗体方面的应用
CN109721642B (zh) * 2018-12-26 2021-08-24 乾元浩生物股份有限公司 一种i群血清4型-血清8型禽腺病毒二价亚单位疫苗及其制备方法
CN110616278B (zh) * 2019-08-09 2022-08-12 山东省农业科学院家禽研究所 检测fav-8和fav-11的特异性引物及试剂盒
CN111269892B (zh) * 2020-03-06 2023-07-11 哈尔滨科欣农业科技有限公司 I群4型禽腺病毒dn株、禽腺病毒灭活疫苗及其制备方法和应用
CN112048570A (zh) * 2020-08-12 2020-12-08 广东省农业科学院动物卫生研究所 一种检测鸭腺病毒4型的pcr引物及其检测方法与应用
CN112626279A (zh) * 2021-01-21 2021-04-09 福建省农业科学院畜牧兽医研究所 检测新发鸭4型腺病毒的实时荧光定量pcr引物及试剂盒
CN112852760A (zh) * 2021-03-04 2021-05-28 温氏食品集团股份有限公司 重组鸭肠炎病毒及其应用
CN113198011B (zh) * 2021-04-28 2023-05-09 重庆永健生物技术有限责任公司 一种鸭腺病毒3型菌株灭活疫苗及其应用
KR102656435B1 (ko) * 2021-12-13 2024-04-11 주식회사 중앙백신연구소 신규한 가금 아데노바이러스 및 이를 유효성분으로 포함하는 가금 아데노바이러스 다가백신
EP4205759A1 (en) 2022-01-04 2023-07-05 Veterinärmedizinische Universität Wien Fowl adenovirus subunit vaccine and production method thereof
CN114703153B (zh) * 2022-06-06 2022-08-02 广东省农业科学院动物卫生研究所 一株血清2型禽腺病毒毒株以及疫苗和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615803A1 (de) 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
WO2003039593A1 (en) 2001-11-08 2003-05-15 Akzo Nobel N.V. Fowl adenovirus vaccine
EP1601771A1 (en) * 2003-03-04 2005-12-07 Abic Ltd. Subunits of the adenovirus fiber protein and uses thereof as vaccines
US8080642B2 (en) * 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
CA3177833A1 (en) * 2009-12-15 2011-06-15 University Of Saskatchewan Vaccines for inclusion body hepatitis
EP2839838A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839841A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine

Also Published As

Publication number Publication date
US10220088B2 (en) 2019-03-05
WO2015024929A3 (en) 2015-05-07
JP2016528270A (ja) 2016-09-15
AU2014310676A1 (en) 2016-03-03
US20160199484A1 (en) 2016-07-14
EP2839841A1 (en) 2015-02-25
CA2921394C (en) 2023-09-05
CA2921394A1 (en) 2015-02-26
ES2896483T3 (es) 2022-02-24
EP3035963B1 (en) 2021-10-20
MX2016002104A (es) 2016-11-11
AU2014310676A2 (en) 2016-05-12
MX371174B (es) 2020-01-20
EP3035963A2 (en) 2016-06-29
AU2014310676B2 (en) 2019-09-12
BR112016003338A2 (pt) 2017-11-21
WO2015024929A2 (en) 2015-02-26
CL2018001159A1 (es) 2018-06-22
BR112016003338B1 (pt) 2023-03-07
JP6577470B2 (ja) 2019-09-18

Similar Documents

Publication Publication Date Title
CL2016000358A1 (es) Vacuna para adenovirus aviar
BR112016012894A2 (pt) Artigo para fumar que compreende uma fonte de calor combustível isolada
CL2015003440A1 (es) Composiciones de arni contra tmprss6 y métodos para su uso
BR112016003317A2 (pt) vacina para adenovírus aviário
BR112016002199A2 (pt) Proteína anti-garp e usos da mesma
BR112015023679A2 (pt) composições e métodos para imunoterapia
DK2970930T4 (da) Kombinatoriske alpha-amylasevarianter
FI20135610A (fi) Itsesäätyvä massavaimennin ja tämän käsittävä järjestelmä
BR112015027743A2 (pt) métodos para preparar frações de lignina termicamente estáveis
DK3508209T3 (da) Sammensætninger med et svækket newcastle sygdoms-virus og fremgangsmåder til anvendelse til behandling af neoplasi
CR20150170A (es) Vacunas de inmersión subunidad para peces
BR112016029860A2 (pt) conjugados de anticorpo antirreceptor alfa de folato (fra)-fármaco e métodos de uso dos mesmos
DK4129330T3 (da) Sammensætninger og fremgangsmåder til kimære dengue virus-konstruktioner i vacciner
CL2016000392A1 (es) Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
DK2956410T3 (da) Kompositsilicium- eller komposittinpartikler
EP3009466A4 (en) SILICONE MODIFIED BY A DIGLYCERIN DERIVATIVE CONTAINING LONG CHAIN HYDROCARBON GROUPS AND USE THEREOF
BR112016020181A2 (pt) Composições de ácido lipoico éster colina e métodos de uso.
BR112015016548A2 (pt) polimixinas , composições , métodos de preparação e métodos de uso
CL2016001153A1 (es) Vacuna para peces.
BR112015016088A2 (pt) bomba centrífuga com efeito coalescente, método de execução de projeto e uso da mesma
EP3008176A4 (en) COMPOSITIONS AND METHODS FOR REINFORCING THE VIRUS REPLICATION
BR112015032388A2 (pt) métodos e composições para as vacinas contra o vírus da dengue
SG11201510266SA (en) Dengue virus vaccine compositions and methods of use thereof
CL2016001152A1 (es) Vacuna para peces